[1] Moreau R, Jalan R, Gines P, et al. Acute-on- chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology, 2013,144:1426-1437.
[2] Malinchoc M, Kamath PS, Gordon FD,et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology,2000,31:864-871.
[3] Jalan R, SaLiba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol,2014,61:1038-1047.
[4] O'leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology,2018;67:2367-2374.
[5] Hernaez R, Liu Y, Kramer JR, et al. Model for end-stage liver disease-sodium underestimates 90-day mortaLity risk in patients with acute-on-chronic liver failure. J Hepatol, 2020,73:1425-1433.
[6] Jalan R, Arroyo V. Organ allocation for patients with acute-on-chronic liver failure: Time to look beyond MELD-sodium? J Hepatol,2020,73:1316-1318. |
